Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Plunkett currently holds 526,210 shares of CELL THERAPEUTICS INC (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Plunkett has been a net seller of CTIC stock. They have purchased $0 and sold $1.8M worth of shares.
Matthew Plunkett's most recent insider trade was on Mar 21, 2016, when they sold 63,874 shares at $0.55 per share.
Matthew Plunkett serves as Executive at CELL THERAPEUTICS INC (CTIC). They have executed 298 insider transactions totaling $1.8M over their tenure at the company.
Matthew Plunkett holds the position of Executive at CELL THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Matthew Plunkett has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Plunkett was on Mar 21, 2016, when they sold $35.1K worth of CTIC shares. This transaction involved 63,874 shares at $0.55 per share.
Matthew Plunkett currently owns 526,210 shares of CELL THERAPEUTICS INC (CTIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Plunkett's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Plunkett has 298 Form 4 filings on record as an insider at CELL THERAPEUTICS INC.
Set alerts for Matthew Plunkett and 40,000+ other insiders.